GSK vs AAPL · P/E 13, $103.31B cap vs P/E 39, rev $416.16B
GlaxoSmithKline PLC ADR (GSK) versus Apple Inc (AAPL) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Apple Inc (AAPL) is a consumer electronics company listed on US. It is led by Timothy D. Cook.
GSK does not have a complete income-statement cache yet.
Latest reported AAPL revenue for 2025-09-27 was $416.16B. Net income was $112.01B. Revenue was up 6.4% from 2024-09-28 to 2025-09-27. AAPL currently screens at market cap $3.83T and trailing P/E 39.2.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. AAPL currently screens at market cap $3.83T and trailing P/E 39.2.
Not investment advice. Open the GSK and AAPL stock pages for the full models.
Not investment advice.